John Leonard, CFA
Special situations, micro-cap, contrarian, CFA

Ocean Bio-Chem Is Undervalued, Overlooked And On The Verge Of Disrupting Multiple Markets

(Editors' Note: This article covers a stock that is trading at less than $1 per share and/or has less than a $100 million market cap. Please be aware of the risks associated with these stocks.)

Key takeaways

    Ocean Bio-Chem (NASDAQ:OBCI) trades at an attractive multiple as higher, growth-related marketing expenses and non-recurring legal expenses result in temporary lower EBITDA. This discount to intrinsic value is magnified by the nanocap status and lack of analyst coverage. The market is ignoring the growth potential in disrupting large markets with its "game changing" products. As a result, investors have the opportunity to buy an existing great business with a wide moat for a mid single-digit multiple and get the growth prospects ...
Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details